The New Jersey Business & Industry Association opposed three new proposed health insurance coverage mandates released by Senate committees Thursday because the bills had not been reviewed by the independent state commission tasked with determining the impact on policyholders’ premiums and the state budget. NJBIA Vice President for Health and Legal Affairs Mary Beaumont said […]
health insurance mandates
Senate Bill 2793 (Weinberg)
On behalf of our 20,000 members, the New Jersey Business & Industry Association (NJBIA), respectfully OPPOSES Senate Bill 2793 (Weinberg). This bill requires health insurers, SHBP and SEHBP to provide coverage for digital tomosynthesis for screening and diagnostic purposes related to breast cancer. NJBIA is concerned that this measure has not been reviewed by the […]
Senate Bill 659 (Turner) – Requires health insurance coverage for contraceptives to include prescriptions for 12 months.
On behalf of our 20,000 members, the New Jersey Business & Industry Association (NJBIA), respectfully OPPOSES Senate Bill 659 (Turner). This bill requires health coverage for contraceptives to include prescriptions for 12 months. NJBIA is concerned that this measure has not been reviewed by the Mandated Health Benefits Advisory Commission prior to being heard in […]
Assembly Bill 1977 (Prieto; Mukherji; Benson; Vainieri Huttle) – Requires health benefits coverage for mammograms for women under 40 who lack access to family medical history due to their or their parent’s adoption.
On behalf of our 20,000 members, the New Jersey Business & Industry Association (NJBIA), respectfully OPPOSES Assembly Bill 1977 (Prieto, Mukherji, Benson, Vainieri Huttle). This bill requires health benefits coverage for mammograms for women under 40 who lack access to family medical history due to their or their parent’s adoption. We would respectfully request […]
Assembly Bill 1007 (Jasey, Tucker) – Requires insurers to provide coverage for medications and dose-intensive chemotherapy/bone marrow transplants and umbilical cord blood transplants for treatment of sickle cell anemia.
On behalf of our 20,000 members, the New Jersey Business & Industry Association (NJBIA), respectfully OPPOSES Assembly Bill 1007 (Jasey, Tucker). This bill requires insurers to provide coverage for medications and dose-intensive chemotherapy/bone marrow transplants and umbilical cord blood transplants for treatment of sickle cell anemia. NJBIA is concerned that this measure has not been […]